Launch Edition by Informa Markets in India Showcases Global Leadership in Medical Technology and Sustainable Healthcare Solutions, attracts over 4000 attendees The launch edition of India Health exhibition, organised by Informa Markets in India, concluded successfully at the state-of-the-art Yashobhoomi in Dwarka, New Delhi. The
Aims for 60-70 % market share in next three years, thanks to our innovative Dispojekt syringes with safety needle:Mr Sohail Nath Dispojekt safety needle syringes will give boost to our collective efforts to check NSIs leading to Hepatitis and HIV among healthcare workers, with an estimated 44.5% of healthcare workers experiencing at
As India celebrates its 75th Republic Day, it is a moment of reflection and pride for the nation. The journey from an independent nation to one of the world's fastest-growing economies in a relatively shorter period has been remarkable. By 2027, the nation is poised
Sanofi India Limited (SIL) today announced the appointment of Himanshu Bakshi as General Manager for its Consumer Healthcare (CHC) business, effective 15th January 2024. With a vision of building the best Fast Moving Consumer Healthcare, (FMCH) company in the world and for the world, SIL earlier
Venus Remedies has secured regulatory approval from Philippines for chemotherapy medication paclitaxel and zoledronic acid, a drug used to treat metabolic bone disorders The company has also received marketing authorisation for another chemotherapy drug, bleomycin, from Saudi Arabia While Saudi Arabia is the largest
Board approves the separation of Aster’s India and GCC businesses, subject to regulatory and corporate approvals including Aster India’s shareholders’ approval. The separation plan will unlock value for the shareholders by allowing both the India and GCC businesses to adopt a market-focused strategy and
Obtaining market authorization for Bleomycin from MHRA is a momentous accomplishment for Venus Pharma GmbH. Venus Remedies holds a total of 15 Market Authorizations (MA) for Bleomycin products across the globe. Venus Remedies is thrilled to announce the achievement of market authorization in the United Kingdom
The first international sale of the SSi Mantra was delivered to Dubai, United Arab Emirates Additional International Sales Expected SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of the “SSi Mantra,” a versatile and cost-effective surgical robotic system, today announced that it
One-Stop Facility with cGMP Manufacturing to Bolster AMEA’s Biopharma Industry Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies, and applied materials industries, today inaugurated its expanded Singapore Hub which includes newly added cGMP manufacturing
Dr. Azad Moopen, Founder Chairman and MD of Aster DM, attends CEO Roundtable Session and Co-chairs session on the Continuum of Integrated Healthcare Aster’s MVT Unit Serves More Than 4000 international patients from Middle East, East and West Africa and SAARC countries Aster
